NASDAQ
CytomX Therapeutics, Inc. (CTMX) has a current ratio of 3.09x as of Monday, May 25, 2026. This represents a 55.09% increase compared to its 12-month average of 1.99x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.